United States: Capitalizing On Collaboration – The President's Precision Medicine Initiative

Last week President Obama marked the one year anniversary of his Precision Medicine Initiative ("PMI") by holding a web-accessible panel discussion where he and interested stakeholders discussed his PMI initiative, its progress and future direction. The President also announced a series of awards, funded by the National Institutes of Health ("NIH"), to build the infrastructure and data collection tools necessary to support the voluntary research cohort who will share health, familial and genetic information. (For more information on the voluntary research cohort, see my prior post of January 26, 2016).

Private-Public Partnerships

The PMI initiative is not limited to the public sector. The President announced that more than 40 private-sector organizations made commitments to PMI. Several public-private partnerships were announced to advance the PMI:

Vanderbilt University in collaboration with Verily (formerly Google Life Sciences) received a grant to lay the foundation for a national community of 1 million or more U.S. volunteers who will partner with researchers to share personal health data;

The NIH and the Health Resources and Services Administration will partner with several health centers to develop, pilot, and refine approaches to engaging underserved and underrepresented individuals, families, and communities to ensure diversity in the data collected to support PMI;

The NIH and the Office of the National Coordinator for Health IT will create "Sync for Science" pilots through an open standards development process with electronic health record developers Allscripts, athenahealth, Cerner, drchrono, Epic and Mckesson;

The Office of the National Coordinator for Health IT and the National Institute of Standards and Technology (NIST), will develop a precision medicine-specific guide to the NIST Cybersecurity Framework to obtain individual input on best practices in security and data management for precision medicine;

The Department of Veterans Affairs and the Department of Defense will expand a participant-driven research cohort with more than 450,000 veteran enrollees; and

The Food and Drug Administration announced the launched its first precisionFDA challenge, which will use the new precisionFDA platform to encourage the genomics community to advance quality standards and achieve more consistent and accurate DNA test results.

Progress for Personalized Medicine

The President's PMI received additional commitments from the private sector to enable patient-access to and the sharing of their data. Several notable examples include, for example: Allscripts, athenahealth, Cerner, crchrono, Epic and Mckesson reported that they will pilot the use of open, standardized application programming interface ("API') to allow patient's access to their own electronic health records;

Carolinas Healthcare System will use a new mobile application that allows patients to view their data from multiple devices. Get My Data is a newly formed not-for-profit group organized to raise public awareness of the right of individuals to access and control their data;

The University of California Health System announced its commitment to giving patients the tools to download their health data from any of the five UC Health medical systems;

Foundation Medicine also announced it is releasing the world's largest, real-world genomics dataset of common and rare pediatric cancers to help develop targeted therapies specifically for pediatric cancer;

IBM and New York Genome Center committed to creating a comprehensive, open cancer data repository, using cognitive insights from IBM's Watson computer system to accelerate cancer research and scale access to precision medicine. The project will begin with a pilot to sequence tumors from 200 cancer patients and compare how different types of sequencing inform and improve cancer care;

Inova Health System, a non-profit healthcare system serving more than 2 million people per year, announced that it will set up a new venture investment fund in excess of $100 million focused exclusively on precision medicine;

Intel also announced a precision medicine initiative, the Precision Medicine Acceleration Program, to develop and release an open source proof of concept for data center infrastructure to support processing, storage, and analysis of large precision medicine data sets; and

Microsoft reported that by the end of this year, it will host large, open genomics data sets on the Microsoft Azure cloud platform at no cost.

Clinical Adoption of Precision Medicine

Progress is not limited to enabling tools for precision medicine. Several significant clinical programs were announced. The Multiple Myeloma Research Foundation (MMRF), announced the MMRF Patient Journey Initiative to educate tens of thousands of patients and their families on the critical steps in the patient journey and the actions they can take to maximize their precision care from diagnosis through the course of their disease. St. Elizabeth Healthcare plans to assess and operationalize the use of a precision medicine pharmacogenomics test to identify the specific type and dosage of medicine to prescribe based on the patient's genetic profile.

Stanford Medicine announced its plant to launching a consultative pharmacogenetics practice in 2016 so that physicians can refer patients with unusual drug responses or with a family history of unusual responses. University of Arizona Health Sciences (UAHS) committed to $22 million to expand the clinical utility of its open-source, patient-centric analytic methods to aid physicians in interpreting disease-associated gene expression changes arising from patients' own DNA blueprint. UAHS also announced the three new precision medicine initiatives. The first is an on-demand "case-based reasoning" system that intelligently searches and analyzes entire databases of electronic medical records. The second is the development of genetic assays to predict an individual's response to therapy and prevention of adverse reactions. The third is a partnership with five other institutions to advance the Sanford Pediatric Genomics Consortium to improve health care decision-making through better understanding and integration of genomic evidence.

And There's More...

Many additional programs were announced by the White House that support and promote the President's initiative. A full summary of the initiatives is found on the White House web page, accessible here. The initiative's scope, depth and commitments from the public and private sectors virtually ensure its success to the benefit of our nation's future health.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.